NCT03290027View on ClinicalTrials.gov

A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

April 19, 2018

Study Completion Date

April 19, 2018

Conditions
Acne Vulgaris
Interventions
DRUG

DFD-03

DFD-03 Lotion

OTHER

Placebo Comparator

Vehicle (tazarotene 0%) Lotion

Trial Locations (1)

75024

Dr. Seemal, Plano

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY